abstract |
The present invention relates to 4- [5-methoxy-6- (2-methyl-6- [1,2,4] triazol-1-yl-pyridin-3-ylamino) -p irimidin-4 acid isopropyl ester -yloxy] piperidine-1-carboxylic, pharmaceutically acceptable salts, solvates and hydrates thereof that are modulators of glucose metabolism. Accordingly, the compounds of the present invention are useful in the treatment of disorders related to metabolism and its complications, such as diabetes and obesity. (Formula I). |